Thông tin thuốc gốc
Chỉ định và Liều dùng
Short-term management of anxiety
Adult: Initially, 5 mg bid or tid, gradually increase by increments of 5 mg at 2-3 days interval. Usual dose: 15-30 mg daily in divided doses. Max: 60 mg daily.
Nhóm bệnh nhân đặc biệt
Patients taking potent CYP3A4 enzyme inhibitors: Initially, 2.5 mg once daily or bid, adjust based on clinical assessment.
Suy thận
CrCl (mL/min) Dosage
<20 Contraindicated.
20-49  Initially, 5 mg bid. 
Suy gan
Severe: Contraindicated.
Cách dùng
May be taken with or without food. Take consistently either always w/ or always w/o meals.
Chống chỉ định
Epilepsy. Concomitant use w/ MAOIs. Severe renal (CrCl <20 mL/min) or hepatic impairment. Lactation.
Thận trọng
Patient w/ acute narrow-angle glaucoma, myasthenia gravis, drug dependence. Renal or hepatic impairment.
Tác dụng không mong muốn
Nervousness, insomnia, disturbance in attention, depression, confusion, seizure, sleep disorder; dizziness, headache, light-headedness, excitement, somnolence, paraesthesia, blurred vision, coordination disorder, tremor, tinnitus; tachycardia, palpitation, chest pain; nasal congestion, pharyngolaryngeal pain; nausea, abdominal pain, dry mouth, diarrhoea, constipation, vomiting; cold sweat, rash, musculoskeletal pain, fatigue. Rarely, angioneurotic oedema, ecchymosis, urticaria.
Thông tin tư vấn bệnh nhân
This drug may cause sedation and dizziness, if affected, do not drive or operate machinery.
Chỉ số theo dõi
Monitor mental status.
Quá liều
Symptoms: Nausea, vomiting, dizziness, drowsiness, miosis, gastric distress, mild bradycardia, hypotension, extrapyramidal symptoms, and convulsions. Management: Symptomatic and supportive treatment w/ immediate gastric lavage. May consider activated charcoal w/in 1 hr of ingestion of >5 mg/kg.
Tương tác
Increased serum concentration when used w/ CYP3A4 enzyme inhibitors (e.g. erythromycin, itraconazole, nefazodone, ritonavir, diltiazem, verapamil). Decreased metabolism and therapeutic effect when used w/ CYP3A4 enzyme inducers (e.g. rifampicin). Enhanced sedative effect w/ baclofen, lofexidine, nabilone, antihistamines. May increase serum concentration of haloperidol. Buspirone does not exhibit cross-tolerance w/ sedative/hypnotics (e.g. benzodiazepine) and will not block symptoms of their withdrawal, gradually withdraw such agents prior to initiation of buspirone.
Potentially Fatal: Increased BP when taken w/ MAOIs.
Tương tác với thức ăn
Enhanced sedative effects w/ alcohol. Food may delay absorption and decrease first-pass metabolism, thereby increasing bioavailability. Grapefruit juice may increase buspirone concentration.
Ảnh hưởng đến kết quả xét nghiệm
May cause false-positive result on urinalysis for metanephrine/catecholamine.
Tác dụng
Description: Buspirone, an azaspirodecanedione, is an anxioselective drug w/ only little sedative effect but w/o anticonvulsant and muscle relaxant properties. It has high affinity for serotonin (5-HT1A and 5-HT2), moderate affinity for dopamine (D2), and no affinity for GABA receptors.
Onset: W/in 2 wk.
Absorption: Rapidly and almost completely absorbed from the GI tract. Bioavailability: 1.5%-13%. Time to peak plasma concentration: W/in 40-90 min.
Distribution: Volume of distribution: 5.3 L/kg. Plasma protein binding: Approx 86%-95%, mainly to albumin.
Metabolism: Extensively metabolised in the liver by CYP3A4 enzyme via oxidative dealkylation to 1-pyrimidinylpiperazine as active metabolite and via hydroxylation to inactive metabolites; undergoes extensive first-pass metabolism.
Excretion: Via urine (approx 29-63%, mainly as metabolites); faeces (approx 18-38%). Elimination half-life: 2-3 hr.
Đặc tính

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Database. Buspirone, CID=2477, https://pubchem.ncbi.nlm.nih.gov/compound/Buspirone (accessed on Jan. 22, 2020)

Bảo quản
Store between 15-30°C. Protect from light.
Phân loại MIMS
Thuốc giải lo âu
Phân loại ATC
N05BE01 - buspirone ; Belongs to the class of azaspirodecanedione derivatives anxiolytics. Used in the management of anxiety, agitation or tension.
Tài liệu tham khảo
Anon. Buspirone. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 10/08/2016.

Buckingham R (ed). Buspirone Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 10/08/2016.

Buspirone Hydrochloride Tablet (Accord Healthcare Inc). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 10/08/2016.

Joint Formulary Committee. Buspirone Hydrochloride. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 10/08/2016.

McEvoy GK, Snow EK, Miller J et al (eds). Buspirone Hydrochloride. AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 10/08/2016.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Buspirone từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2022 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in